CN Patent

CN115785183A — 一种3α,7α-二羟基-6α-乙基-5β-胆烷-24-醛的制备方法及其应用

Assigned to Jiangxi Kerui Pharmaceutical Co ltd · Expires 2023-03-14 · 3y expired

What this patent protects

本发明涉及3α,7α‑二羟基‑6α‑乙基‑5β‑胆烷‑24‑醛的制备方法，简单方便，产率和含量高，能较方便的用作奥贝胆酸或其衍生物质量控制的有关物质对照品，或用于奥贝胆酸或其衍射物的杂质鉴定，利于奥贝胆酸或其衍生物生产过程中的检测控制及含奥贝胆酸或其衍生物药品的质量控制。

USPTO Abstract

本发明涉及3α,7α‑二羟基‑6α‑乙基‑5β‑胆烷‑24‑醛的制备方法，简单方便，产率和含量高，能较方便的用作奥贝胆酸或其衍生物质量控制的有关物质对照品，或用于奥贝胆酸或其衍射物的杂质鉴定，利于奥贝胆酸或其衍生物生产过程中的检测控制及含奥贝胆酸或其衍生物药品的质量控制。

Drugs covered by this patent

Patent Metadata

Patent number
CN115785183A
Jurisdiction
CN
Classification
—
Expires
2023-03-14
Drug substance claim
No
Drug product claim
No
Assignee
Jiangxi Kerui Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.